Inhibitor Therapeutics (INTI) Selling, General & Administrative (2012 - 2026)
Inhibitor Therapeutics (INTI) posted Selling, General & Administrative of $395,033 for Q2 2026, up 6.7% from $370,150 a year earlier and up 11.3% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Selling, General & Administrative (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Inhibitor Therapeutics was $1.67 million, down 9.6% year-over-year; for FY2025, it came in at $1.73 million, down 8.9% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- In prior years, Inhibitor Therapeutics' Selling, General & Administrative was $1.9 million in FY2024 (-6.1%), $2.02 million in FY2023 (+210.5%), $651,776 in FY2022 (+103.4%) and $320,490 in FY2021 (-63.3%).
- Quarterly Selling, General & Administrative has run from a low of $28,684 in Q4 2021 to a high of $596,455 in Q4 2024 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in three of the last eight quarters, with an average decline of 6.8%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2023, with growth of 686.4%; the weakest was Q3 2021, with a decline of 75.5%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $355,070 (Q1 2026), $557,866 (Q4 2025) and $363,426 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 395,033.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 395,033.00 |
| Mar 31, 2026 | 355,070.00 |
| Dec 31, 2025 | 557,866.00 |
| Sep 30, 2025 | 363,426.00 |
| Jun 30, 2025 | 370,150.00 |
| Mar 31, 2025 | 438,493.00 |
| Dec 31, 2024 | 596,455.00 |
| Sep 30, 2024 | 443,575.00 |
| Jun 30, 2024 | 345,371.00 |
| Mar 31, 2024 | 514,458.00 |
| Dec 31, 2023 | 588,356.00 |
| Sep 30, 2023 | 498,763.00 |
| Jun 30, 2023 | 508,468.00 |
| Mar 31, 2023 | 428,326.00 |
| Dec 31, 2022 | 423,635.00 |
| Sep 30, 2022 | 69,987.00 |
| Jun 30, 2022 | 64,654.00 |
| Mar 31, 2022 | 93,500.00 |
| Dec 31, 2021 | 28,684.00 |
| Sep 30, 2021 | 66,248.00 |
API Access
Inhibitor Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();